Danish Medicines Council decisions from April 2026

Breaking: Denmark speeds up access to PD-(L)1 immunotherapies

Lif launches vaccine proposal: Denmark falls behind on vaccination efforts

NICE greenlights Rystiggo for uncontrolled gMG via interim NHS funding

Cancer care needs innovation that translates into real patient benefit

TLV revises guidelines to price adjustments for high sales value

CHMP issues positive opinion for five new medicines and nine extensions

Palko begins work on Breyanzi recommendation

Sweden lacks a national adult vaccination program

NHTA collaborates with DTU Computerome for Nordic Real-world evidence studies